Document is current

Article History

Received: 19 April 2024

Accepted: 13 August 2024

First Online: 1 October 2024

Declarations

:

: The Ethics Committee of the Faculty of Medicine, University of Leipzig, reviewed and approved the study (297/16-ek). All participants gave their written informed consent.

: Not applicable.

: CG has received honoraria for consulting and lectures within the past three years from Allergan/AbbVie, Lilly, Novartis Pharma, Hormosan Pharma, Grünenthal, Sanofi-Aventis, Weber & Weber, Lundbeck, Perfood, Vectura, Chordate, betapharm, Pfitzer, and TEVA. His research is supported by a grant of the German Research Foundation (DFG). He does not hold any stocks of pharmaceutical companies. TJ has served on advisory boards and/or has received honoraria for lectures from Alleregan, Grünethal, Hormosan, Lilly, Lundbeck, Novartis, Sanofi, and TEVA. PK has received funding from Takeda, travel and lecture fees from Novartis, Lilly, and Teva. RR has received travel grants and/or honoraria from Allergan/AbbVie, Hormosan, Lilly, Novartis and Teva. AS has received honoraria for lectures and consultations within the past 3 years from Allergan, Hormosan, Lilly, Novartis, Sanofi, and Teva. SF has received honoraria for lectures and consultations within the past 3 years from Allergan, Hormosan, Lilly, Lundbeck, Novartis, Sanofi, and TEVA. FR has served on advisory boards and/or has received honoraria for lectures from Alleregan/Abbvie, Hormosan, Lilly, Lundbeck, Novartis, Ipsen, and TEVA. TD has received honoraria for consulting and lectures within the past 3 years from Hormosan Pharma, Novartis Pharma, and TEVA. EB, BM, and OR declare that they have nothing to disclose